Jiangsu Hengrui Pharmaceuticals Co., Ltd. (0BO)
FSX
5.55
+0.15 (+2.78%)
Closed
Oct 7, 2026
Day's Range
5.455.55
52 wk Range
4.8210.40
Financial Statements - 0BO - Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Revenue
31.62B▲ 13.0%
Net Income
7.71B▲ 21.8%Net Margin 24.4%
EBITDA
9.49B▲ 21.2%
Free Cash Flow
8.27B▲ 51.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 31.62B | 27.98B |
| Cost of Goods | 4.36B | 3.84B |
| Gross Profit | 27.26B | 24.13B |
 Operating Expense | - | - |
| Operating Income | 8.59B | 6.80B |
| Non-Operating Interest | - | - |
| Other Income Expense | - | - |
| Pre Tax Income | 8.70B | 7.16B |
| Income Tax | 990.62M | 832.69M |
| Net Income | 7.71B | 6.33B |
| EPS Basic | 1.19 | 1 |
| EPS Diluted | 1.18 | 1 |
| Basic Shares Outstanding | 6.47B | 6.33B |
| Diluted Shares Outstanding | 6.47B | 6.33B |
| Ebit | 8.72B | 7.17B |
| Ebitda | 9.49B | 7.84B |
| Net Income Continuous Operations | 7.71B | 6.33B |
| Minority Interests | -5.94M | -467.63K |
| Preferred Stock Dividends | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
